JAN 30, 2019 04:46 PM PST

Hens Engineered to Generate Human Proteins in Their Eggs

WRITTEN BY: Carmen Leitch

Chicken eggs have been used for over 70 years to produce vaccines. Now researchers have used genetically modified chickens to generate large amounts of human proteins in their eggs. This research could offer a cost-effective way to make certain protein-based drugs. Such drugs include recombinant human insulin and cancer therapeutics as well as many other different types, including monoclonal antibodies and cytokines. Some of these drugs are very expensive, and this work could help change that.

It’s been shown that genetically modified animals like chickens and goats can produce these types of therapeutics in the eggs or milk they make. Researchers have now successfully generated high levels of two specific proteins in chicken eggs. The protein could then be easily purified from the eggs, making them ideal bioreactors. The chickens used in this work did not have any health problems, the researchers said, and they laid eggs normally. The work has been reported in BMC Biotechnology and is briefly outlined in the video.

"We are excited to develop this technology to its full potential, not just for human therapeutics in the future but also in the fields of research and animal health,” said Dr. Lissa Herron, the Head of the Avian Biopharming Business Unit at Roslin Technologies. This study was conducted at the Roslin Institute of the University of Edinburgh and Roslin Technologies, a company that aims to bring research from The Roslin Institute to the market.

For this proof-of-concept study, the team focused on two proteins that play important roles in the immune system, and have the potential to be used as therapeutics. The first was the human cytokine interferon α2a, which could be useful in the treatment of cancer and viral diseases; the other was the human and pig macrophage-CSF protein, which is now being investigated as a way to induce repair in damaged tissues. The protein production was specific to the oviduct, so the protein only appeared in the egg white.

Only three eggs were needed to produce enough drug for a clinically relevant dose. The average chicken can lay around 300 eggs a year, so this could be a much better way to make some crucial drugs.

Scientists at the University of Edinburgh's Roslin Institute have produced GM chickens that make human proteins in their eggs, offering a more cost-effective method of producing certain types of drugs. / Credit: Norrie Russell, The Roslin Institute

This drugs in this work have not yet been tested in people, however. 

"We are not yet producing medicines for people, but this study shows that chickens are commercially viable for producing proteins suitable for drug discovery studies and other applications in biotechnology,” explained Professor Helen Sang, of the University of Edinburgh's Roslin Institute. 

"These recent findings provide a promising proof of concept for future drug discovery and potential for developing more economical protein-based drugs,” added Dr. Ceri Lyn-Adams, Head of Science Strategy, Bioscience for Health with BBSRC, said: 


Sources: Science Daily via University of Edinburgh, CDC, Veterinary Immunology and Immunopathology, BMC Biotechnology

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 20, 2019
Microbiology
NOV 20, 2019
Salmonella Becomes More Deadly and Drug-Resistant in Central Africa
An international team of scientists has identified strains of extensively drug-resistant Salmonella typhimurium....
NOV 20, 2019
Genetics & Genomics
NOV 20, 2019
Hypersexual Disorder Caused by Faulty Genes
Hypersexual disorder is a condition in which people experience sexual fantasies and urges so intense that they disrupt their daily lives. Affecting be...
NOV 20, 2019
Genetics & Genomics
NOV 20, 2019
A More Precise Version of CRISPR/Cas9 is Created
A more accurate version of Cas9 has been created, reducing the number of off-target effects. It may be better suited for use in gene therapy....
NOV 20, 2019
Genetics & Genomics
NOV 20, 2019
Researchers Develop a Score to Quantify the Risk of Epilepsy
It usually takes two seizures before a person can be diagnosed with epilepsy. New work can help change that....
NOV 20, 2019
Cell & Molecular Biology
NOV 20, 2019
Scientists Create a New Version of CRISPR - Prime Editing
A new technique enables researchers to target and modify one base pair out of billions, and could correct disease-causing mutations....
NOV 20, 2019
Technology
NOV 20, 2019
Machine-Learning and Epigenetics Drug Discovery
Machine learning is known for detecting patterns seen in complex data—such uniqueness has proven it roles in health and medicine. Now, researchers at...
Loading Comments...